Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Prevail Therapeutics

Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson's disease and other neurodegenerative diseases. Prevail was launched in 2017 by The Silverstein Foundation for Parkinson's with GBA, REGENXBIO, and OrbiMed, and is headquartered in New York, NY.

Key Contact
NameTitleE-Mail
Asa Abeliovich, M.D., Ph.D.CEO & Founder


Funding Events
DateAmountTypeInvestors
03/08/18$75,000,000Series A Adage Capital Management
Alexandria Venture Investments
Boxer Captial
BVF Partners
EcoR1 Capital
Omega Funds
OrbiMed Advisors
Pontifax
RA Capital
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.